Skip to main content
SpringerLink
Log in

A Study on the Level of T3, T4, TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves’ Hyperthyroidism among South Indian Population

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Graves’ disease (GD) is an organ-specific heterogenous autoimmune disorder associated with T-lymphocyte abnormality affecting the thyroid, eyes and skin. GD is a multifactorial disease that develops as a result of complex interaction between genetic susceptibility genes and environmental factors. It has been suggested that the Cytotoxic T lymphocytes associated molecule-4 (CTLA-4) is a genetic susceptibility candidate for GD. The present study was focused on A/G polymorphism at position 49 in exon-1 of the CTLA-4 gene in 80 GD patients (GP) and 80 sex and age matched healthy individuals among South Indian (Madurai) population. Serum concentrations of thyroid hormone (T4, T3 and TSH) were determined by using automated analyzer. The genomic DNA was isolated from the patient and control groups and genotyping was performed using the polymerase chain reaction followed by restriction enzyme analysis using Bbv1. Significant difference (P < 0.001) was observed in the level of T3, T4 and TSH in GD patients and healthy individuals. The results revealed the CTLA-4 gene G/G genotype to be 32 (40%) in patients and 26 (32.50%) in healthy individuals, A/G genotype to be 37 (46.25%) in patients and 25 (31.25%) in healthy individuals and A/A genotype to be 11 (13.75%) in patients and 29 (36.25%) in healthy individuals. The calculated odds ratio (OR) in individuals with mutant genotype (GG/AG) reveal 3.6 fold risk for GD (95% confidence interval = 1.6–7.8). The mutant “G” allele frequency was observed to be 0.63 in GD patients and 0.48 in healthy individuals. Thus the present study demonstrates an association between the CTLA-4 gene polymorphism and Graves’ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weetman AP, McGregor AM. Autoimmune thyroid disease: further development in our understanding. Endocr Rev. 1994;15:788–830.

    CAS  PubMed  Google Scholar 

  2. Chistiakov DA. Thyroid-stimulating hormone receptor and its role in Graves’ disease. Mol Genet Metab. 2003;80(4):377–88.

    Article  CAS  PubMed  Google Scholar 

  3. Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H. Remission of Graves’ hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T-lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab. 2002;87(6):2593–6.

    Article  CAS  PubMed  Google Scholar 

  4. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Mapping the major susceptibility loci for familial Graves’ and Hashimoto’s disease evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab. 1999;84:4656–64.

    Article  CAS  PubMed  Google Scholar 

  5. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA-4 alanine-17 confers genetic susceptibility to Graves’ disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab. 1997;82(1):143–6.

    Article  CAS  PubMed  Google Scholar 

  6. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T. CTLA-4 gene polymorphism confers susceptibility to Graves’ disease in Japanese. Thyroid. 1997;7(6):843–6.

    Article  CAS  PubMed  Google Scholar 

  7. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ, Cho BY. Polymorphism in the promotor and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid. 2000;10:453–9.

    Article  CAS  PubMed  Google Scholar 

  8. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves’ disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80:41–5.

    Article  CAS  PubMed  Google Scholar 

  9. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves’ ophthalmopathy in European and Japanese populations. Eur J Endocrinol. 2003;148:13–8.

    Article  CAS  PubMed  Google Scholar 

  10. Kotsa K, Watson P, Weetman AP. A CTLA-4 gene polymorphism associated with both Graves’ disease and Hoshimoto’s thyroiditis. Clin Endocrinol (Oxf). 1997;46:551–4.

    Article  CAS  Google Scholar 

  11. Vaidya B, Pearce SHS, Charlton S, Marshall N, Rowan AD, Griffiths ID, Kendall-Taylor P, Cawston TE, Young-Min S. An association between the CTLA-4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology. 2002;41:180–3.

    Article  CAS  PubMed  Google Scholar 

  12. Kouki T, Sawai Y, Gardine CA, Fisfalen M-E, Alegre M-L, Degroot LJ. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogens of Graves, disease. J Immunol. 2000;165:6606–11.

    CAS  PubMed  Google Scholar 

  13. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P. A new member of the immunoglobulin superfamily-CTLA-4. Nature. 1987;328:267–70.

    Article  CAS  PubMed  Google Scholar 

  14. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Dally A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC. The development of Graves’ disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab. 1999;84:2398–401.

    Article  CAS  PubMed  Google Scholar 

  15. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Greene JM, Thompson CB, Bluestone JA. CTLA-4 can function as a negative regulator of T-cell activation. Immunity. 1994;1:405–13.

    Article  CAS  PubMed  Google Scholar 

  16. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP. The role of CTLA-4 in the regulation of T-cell responses. Immunol Rev. 1996;153:27–46.

    Article  CAS  PubMed  Google Scholar 

  17. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction: revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3:541–7.

    Article  CAS  PubMed  Google Scholar 

  18. Vaidya B, Imrie H, Perros P. The cytotoxic T-lymphocyte antigen-4 is a major Graves disease locus. Hum Mol Genet. 1999;8:1195–9.

    Article  CAS  PubMed  Google Scholar 

  19. Kacem HH, Bellassoued M, Bougacha-Elleuch N, Mohamed A. CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease. Clin Immunol. 2001;101(3):351–5.

    Google Scholar 

  20. Wang P-W, Liu R-T, Jou S-HH, Wang S-T, Hu Y-H, Hsieh C-J, Chen M-C, Chen I-Y, Wu C-L. Cytotoxic T lymphocyte associated molecule-4 polymorphism and relapse of Graves’ hyperthyroidism after antithyroid withdrawal. J Clin Endocrinol Metab. 2004;89(1):169–73.

    Article  CAS  PubMed  Google Scholar 

  21. Sambrook J, Russel DW. Molecular cloning, a laboratory manual. 3rd ed. New York: Cold Springer Harbour Laboratory Press; 2001.

    Google Scholar 

  22. Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, Ghaderi A. Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves’ disease. Autoimmunity. 2003;36(5):313–6.

    Article  CAS  PubMed  Google Scholar 

  23. Weng Y-C, Wu M-J, Lin W-S. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves’ disease in the Taiwanese population. Ann Clin Lab Sci. 2005;35:259–64.

    CAS  PubMed  Google Scholar 

  24. Chong KKL, Chiang SWY, Wong GWK, Tam POS, Ng T-K, Hu Y-J, Yam GHF, Lam DSC, Pang C-P. Association of CTLA-4 and IL-3 gene polymorphisms with Graves’ disease and opthalmopathy in Chinese children. Investig Opthalmol Vis Sci. 2008;49:2409–15.

    Article  Google Scholar 

  25. Yung E, Cheng PS, Fok TF, Wong GW. CTLA-4 gene A-G polymorphism and childhood Graves’ disease. Clin Endocrinol. 2002;56:649–53.

    Article  CAS  Google Scholar 

  26. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrin Metab. 2001;86(4):1687–93.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PG and Research Department of Zoology and Biotechnology, Lady Doak College, Madurai, Tamil Nadu, 625 002, India

    P. Veeramuthumari & W. Isabel

  2. Madurai City Hospital and Endocrinology Clinic, East Veli Street, Madurai, Tamil Nadu, India

    K. Kannan

Authors
  1. P. Veeramuthumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Isabel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Kannan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Veeramuthumari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veeramuthumari, P., Isabel, W. & Kannan, K. A Study on the Level of T3, T4, TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves’ Hyperthyroidism among South Indian Population. Ind J Clin Biochem 26, 66–69 (2011). https://doi.org/10.1007/s12291-010-0093-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0093-z

Keywords

Search

Navigation